MAGEA3 and Miyoshi myopathy: Multiple independent functional RNAi screens of both p53 wt and null cell lines demonstrated a strong dependency upon MAGE-A3 for survival [14–16], and loss of p53 through deletions and/or mutations are rare, estimated at less than 5% of newly-diagnosed MM [25].